Skip to content

Advertisement

  • Case report
  • Open Access

Unicentric epithelioid hemangioendothelioma of the calcaneus: a case report and review of literature

Clinical Sarcoma Research20188:5

https://doi.org/10.1186/s13569-018-0092-z

Received: 27 November 2017

Accepted: 7 February 2018

Published: 6 April 2018

Abstract

Background

This review of the literature combined with a clinical case will allow the illustration of a favorable outcome of this variable low grade malignancy, display a role for limb salvage surgery with intralesional treatment, and offer a clinical example of epithelioid hemangioendothelioma, a rare malignancy.

Case presentation

The case report presents a case of solitary epithelioid hemangioendothelioma (EHE) of the calcaneus in a 60-year-old male. Primary vascular tumors of the bone are rare; however, EHE is one of the most common primary malignant vascular tumors to occur in bone. A review of the literature found few cases that involved the calcaneus; those cases found that involved the calcaneus were either part of a multifocal or metastatic disease process. Our case presents a 45-month clinical follow-up of solitary EHE in the calcaneus treated with surgical excision by curettage and cementing.

Conclusion

This case has clinical follow-up greater than 2 years post-operatively and could be a guide for treatment of a rare disorder with a substantial paucity of literature.

Keywords

  • Hemangioendothelioma
  • Epithelioid
  • Angiosarcoma
  • Vascular tumor

Background

Most lytic lesions of bone are a result of metastatic disease; primary bone tumors are far more uncommon. Benign primary bone entities are more common than their malignant counterparts. It was estimated that the age adjusted incidence rate for all bone and joint malignancies is 0.9 per 100,000 persons/year [1]. Epithelioid hemangioendothelioma (EHE) is a vascular tumor that has a propensity to occur in bone. Among vascular tumors, it is considered a low grade malignancy, between hemangioma and angiosarcoma [26]. The low prevalence for primary malignant bone tumors, and thus vascular tumors of bone, has limited the extent of our knowledge. However, there has been much work over the last few decades to help adequately identify and classify EHE and its family of vascular tumors [613].

EHE was given its name by Weiss and Enzinger in 1982 to reflect that it is neither completely benign nor fully malignant [7]. More recently, it has been said that it is the most common malignant vascular tumor of bone, though still relatively rare, accounting for less than 1% of all bone tumors. It has an overall prognosis that favors survival [13]. EHE has been shown to occur slightly more in males [7, 13] and at any age with a peak in the second and third decades of life [4]. The majority of cases have been shown to occur in the lower extremities, primarily the tibia and femur [4, 7, 9, 13]. The most common complaint is local pain at the site of the lesion. Radiographic imaging typically shows a lytic lesion; diagnosis is made with a biopsy and study of the histopathological and immunohistochemical features.

To date, there have been no reports of solitary EHE in the calcaneus. There are a few cases that show the involvement of the calcaneus, all of which occurred in a multifocal or metastatic setting [5, 1417]. In this case report, we describe a solitary EHE of the calcaneus that did not appear on initial radiographic imaging.

Case presentation

A 60-year-old male was evaluated for insidious onset of right foot pain over 4 months, made worse by walking and standing. Radiographs at an outside facility were reportedly normal. Two corticosteroid injections into the sinus tarsus provided no relief. Upon referral new radiographs were obtained (Fig. 1). Magnetic resonance imaging (MRI) showed a complex lesion in the anterior calcaneus with some surrounding edema and potential concern for cortical disruption (Figs. 2, 3). A computed tomography (CT) guided biopsy of the cyst showed a lytic destructive lesion within the central and anterior process of the calcaneus. There was cortical destruction along multiple sites at the margins of the lesion and slight scattered calcifications (Fig. 4). The pathologic report revealed cords and clusters of epithelioid cells and foci of spindle cells in a myxochondroid matrix (Figs. 5, 6). Some of the epithelioid cells contained vacuoles and rare erythrocyte (Fig. 7). Immunohistochemical stains identified CD31, CD34, and CAMTA1 (Figs. 8, 9). Mixed cytokeratin stain (MCK) showed very focal and equivocal staining and D2-40 and epithelial membrane antigen (EMA) were negative. There was extensive necrosis and some spindling but no invasion of the surrounding bone. These findings supported a diagnosis of epithelioid hemangioendothelioma.
Figure 1
Fig. 1

Pre-operative radiograph of large lytic lesion in the calcaneus

Figure 2
Fig. 2

Preoperative sagittal T1 image of the calcaneus showing solid lesion with fairly homogenous signal

Figure 3
Fig. 3

Preoperative sagittal T2 image with some heterogeneity within the lesion surrounding bony edema, sclerotic border around the lesion, but with concern for cortical breakthrough in the subtalar joint

Figure 4
Fig. 4

Axial CT scan of lesion preoperatively displaying concern for cortical destruction

Figure 5
Fig. 5

H&E ×200. The tumor consists of large epithelioid and spindle cells arranged in cords, clusters and as single cells within a myxoid to hyalinized stroma

Figure 6
Fig. 6

H&E ×400. The tumor cells have moderately abundant eosinophilic cytoplasm with occasional cytoplasmic vacuoles. Nuclei are round with prominent nucleoli

Figure 7
Fig. 7

H&E ×600. The vacuoles represent attempts at blood vessel formation and may contain red blood cell fragments

Figure 8
Fig. 8

CAMTA1 immunohistochemical stain, ×200. Tumor cell nuclei stain positively with antibody to CAMTA1 protein, a fusion protein unique to this tumor

Figure 9
Fig. 9

CD34 immunohistochemical stain, ×200. Tumor cells stain positively for endothelial marker CD34. This stain also highlights the anastomosing cord-like architecture of the tumor which recapitulates the formation of primitive blood vessels

The patient was referred to our orthopaedic clinic roughly 6 months after initial presentation. The right lower extremity was neurovascularly intact with no swelling, masses, or skin lesions. There was mild tenderness to palpation of the calcaneus and no palpable nodes in the popliteal or inguinal regions. At this time, radiographs showed a significant cystic lesion with cortical breakthrough and no evidence of collapse. Routine bloodwork was normal. Positron emission tomography/computed tomography (PET/CT) ruled out proximal metastasis; however, bilateral hilar and mediastinal adenopathy were reported along with increased signal in the stomach and bilateral parotid glands.

The patient was taken to the operating room for excision and curettage with argon beam followed by cement filling of the lesion and percutaneous pinning. A biopsy taken during surgery showed the tumor to be histologically the same as the previous biopsy, but now involving the surrounding bone. A thorough oncology and pulmonary workup for the mediastinal adenopathy ruled out metastatic disease, as a biopsy showed a benign anthracotic lymph node with marked histiocytosis. The patient returned to weight bearing activity at 3 months and work after 6 months. CT scan and radiographs of the hindfoot at his 6 month and 3 year follow-up showed well fixed hardware without recurrence (Fig. 10). PET scan at 3 years illustrated stable hilar lymphadenopathy and absence of enhancement of the calcaneus. Other than tolerable pain with extended walking, the patient has made full and tumor free recovery at 3 years.
Figure 10
Fig. 10

Two-year post-operative follow-up radiograph of the calcaneus showing curettage and cementing with Steinman pin reinforcement. There has been so sign of recurrence of disease or failure of the construct despite full activity

Discussion and conclusions

The majority of EHE cases of the bone occur in the lower extremities, followed by the spine [13]. The most common locations in the lower extremity for EHE to occur, in descending order, are the femur, tibia, fibula, and small bones of the feet [4]. Review of the current literature found four cases where the calcaneus was involved; however, none were unicentric. A case presented by Bisbinas et al. [14] described multicentric EHE of the foot and ankle in a 41-year-old male who presented with left foot and ankle pain. Plain radiographs showed multiple osteolytic lesions in the left lower extremity and CT showed no visceral involvement. The patient underwent excision and curettage of all lesions except for one that involved a rib. Biopsy showed no features of malignancy and the patient was alive with no further progression at 5.5 years.

The second case, reported by Liu et al. [5], described another multicentric presentation of EHE in the same lower extremity. The patient was a 59-year-old female who presented with swelling, pain, and functional deficits of her left lower leg. Physical examination demonstrated a 2.0 cm mass on the posterolateral aspect of the proximal lower leg and radiographs illustrated osteolytic lesions. CT showed involvement of the proximal fibula, distal tibia, cuneiform bone, and calcaneus. The patient was treated with fibular head resection and curettage of all other lower extremity lesions, followed by chemical cautery with a phenol solution. There was no local recurrence at 28 months after surgery and no evidence of internal metastasis.

A case report of a 17-year-old male illustrated another multicentric involvement of the lower extremity [18]. This young man presented with persistent pain of his right ankle and radiographs showed multiple bony lesions of the right lower extremity. CT identified lesions in the distal tibia, talus, calcaneus, and first cuneiform with some calcifications. The diagnosis of EHE was established with open biopsy and the patient received radiation therapy of 4600 cGY. No follow-up was reported.

The final case showed involvement of the calcaneus in a 28-year-old woman who presented with a 3-month history of left heel pain made worse by walking [16]. Radiographic imaging revealed a “lytic polylobulated lesion in the left calcaneus” which was not present on plain radiographs 2 months earlier. At a 3-month follow-up, the lytic defect showed slight expansion and an increase in the sclerotic reaction of surrounding bone. CT showed numerous small nodules in both lungs; however, there were no correlative complaints. The patient received adequate resection of the calcaneal lesion only. At 1 year follow-up, CT and MRI showed five small asymptomatic hepatic peripheral nodular lesions with no change in the pulmonary lesions.

As illustrated in our case and the above case reports, the most frequent clinical presentation of EHE of the bone is local pain [69]. Swelling is less commonly noted in the region of the lesion [9]. Radiographic imaging typically shows lytic lesions with a mix of features including surrounding sclerosis [4, 9], cortical destruction and expansion [4, 8, 9], and soft tissue expansion [4, 6, 8, 9]; however, there are no pathognomonic features that can be used to make the diagnosis. It is interesting to note the lack of radiographic evidence upon initial presentation in our case and in the aforementioned 28-year-old female, despite the presence of symptoms persisting greater than 2 months illustrating the variable nature of the malignancy. Clinically, these patients presented with an indolent clinical course; however, the rapid progression over a few months from negative radiographic identification to prominent lytic lesions suggests a rapid cellular development of the malignancy.

Microscopically, these lesions arise from vessels by expanding the vessel in a centrifugal pattern from the lumen extending outward into soft tissue [3, 7]. It has been shown that the majority of cases of EHE arise from veins [3, 7]. The tumor consists of round or cuboid epithelioid endothelial cells with abundant eosinophilic cytoplasm [9] embedded in a loose, lightly basophilic myxoid background [8]. In most cases, there is virtually no mitotic activity. In roughly one quarter of the cases, the “tumor contains areas with significant atypical, mitotic activity (more than 1 mitosis per 10 High Power Field), focal spindling, or necrosis” [3]. The most characteristic feature is the presence of intracytoplasmic vacuoles reminiscent of primitive lumen formation that may contain erythrocytes [4, 8]. This characteristic helps to distinguish it from epithelioid hemangioma and angiosarcoma, as each display well-formed vascular channels [8]. Immunohistochemical staining for CD31, CD34, vimentin, and FLI-1 help identify the vascular origin as the tumor can often be mistaken for metastatic carcinoma [7, 9].

Often the histological features can deviate from what is typical and show a solid growth pattern, epithelioid change, or spindle cell morphology. These changes can complicate the diagnosis. In 2012, Errani et al. [6] reported molecular analysis of 17 cases of EHE at different anatomical locations. They found an “identical genetic translocation [t(1, 3)(1p36.23;3q25.1)] involving the CAMTA1 and WWTR1 genes on chromosomes 1 and 3, respectively”. In 2014, Flucke et al. [12] identified the WWTR-1CAMTA1 fusion gene in 33 of 35 cases of varying anatomical EHE. The remaining two cases were found to contain a second fusion protein, YAP1-TFE3. All cases were identified using either fluorescent in situ hybridization (FISH) and/or reverse transcriptase-polymerase chain reaction (RT-PCR) [12].

There have been no predisposing factors identified [3]. Despite the variable nature of EHE, overall survival is high. In 1996, Kleer et al. [9] reported an overall survival of 89% for unicentric disease and 50% for multifocal disease. In a study of EHE in 62 patients in 2014, Angelini et al. found that 97% with unicentric disease lived to 10 years compared to 74% with multifocal disease [13]. From their study, Angelini et al. encourage using the type of presentation (unicentric vs. multifocal) in conjunction with degree of differentiation of histological features to determine prognosis [13]. Other studies state that atypical histological features (mitotic activity greater than 3/50 per high power field) and tumor size greater than 3 cm, regardless of anatomical location, have a higher rate of mortality [12, 19]. However, 10–15% of cases with histologically “benign appearing EHE metastasize and cause the death of the patient” [3]. Metastasis has been shown to occur in up to 31% of cases and is more common in those with marked cellular atypia, increased mitotic activity, spindling and necrosis [3, 4].

Complete and wide local excision is the proposed method of treatment [36, 9, 13]. Chemotherapy has been used for multifocal and metastatic cases [4, 5, 1113] and radiation therapy alone or as an adjuvant has been successful in multicentric cases [46, 9, 13]. Although radiation can be successful, it should be reserved for cases not amenable to surgery as it has been shown to induce osteosarcoma [13].

Abbreviations

CT: 

computed tomography

EHE: 

epithelioid hemangioendothelioma

EMA: 

epithelial membrane antigen

FISH: 

fluorescent in situ hybridization

MCK: 

mixed cytokeratin stain

MRI: 

magnetic resonance imaging

PET/CT: 

positron emission tomography/computed tomography

RT-PCR: 

reverse transcriptase-polymerase chain reaction

Declarations

Authors’ contributions

MCP wrote the manuscript; PB provided interpretation and written findings of the histological examination. BAL critically reviewed it. All authors read and approved the final manuscript.

Acknowledgements

Not applicable.

Competing interests

BAL reports consultancy for Zimmer Biomet and Highmark, Inc. and research funding from Stryker. PB declares no competing interests MCP declares no competing interests.

Availability of data and materials

Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

Consent for publication

Consent was provided for publication of this case report.

Ethics approval and consent to participate

Not applicable.

Funding

No funding was received in support of this work.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Orthopaedics, West Virginia University, Morgantown, USA
(2)
Department of Pathology, West Virginia University, Morgantown, USA

References

  1. Franchi A. Epidemiology and classification of bone tumors. Clin Cases Miner Bone Metab. 2012;9:92–5.PubMedPubMed CentralGoogle Scholar
  2. Fletcher CDM, editor. WHO classification of tumours of soft tissue and bone. World Health Organization, International Agency for Research on Cancer. Lyon, France: IARC Press; 2013.Google Scholar
  3. Biermann JS. Chapter 22: Benign vascular soft-tissue tumors. OKU 3: Musculoskeletal tumors. New York: Elsevier; 2014. p. 239–45.Google Scholar
  4. Weissferdt A, Moran CA. Epithelioid hemangioendothelioma of the bone: a review and update. Adv Anat Pathol. 2014;21:254–9.View ArticlePubMedGoogle Scholar
  5. Liu Q, Miao J, Lian K, Huang L, Ding Z. Multicentric epithelioid hemangioendothelioma involving the same lower extremity: a case report and review of literature. Int J Med Sci. 2011;8:558–63.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Errani C, Vanel D, Gambarotti M, Alberghini M, Picci P, Faldini C. Vascular bone tumors: a proposal of a classification based on clinicopathological, radiographic and genetic features. Skeletal Radiol. 2012;41:1495–507.View ArticlePubMedGoogle Scholar
  7. Weiss SW, Enzinger FM. Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer. 1982;50:970–81.View ArticlePubMedGoogle Scholar
  8. Hart JL, Edgar MA, Gardner JM. Vascular tumors of bone. Semin Diagn Pathol. 2014;31:30–8.View ArticlePubMedGoogle Scholar
  9. Kleer CG, Unni KK, McLeod RA. Epithelioid hemangioendothelioma of bone. Am J Surg Pathol. 1996;20:1301–11.View ArticlePubMedGoogle Scholar
  10. Evans HL, Raymond AK, Ayala AG. Vascular tumors of bone: a study of 17 cases other than ordinary hemangioma, with an evaluation of the relationship of hemangioendothelioma of bone to epithelioid hemangioma, epithelioid hemangioendothelioma, and high-grade angiosarcoma. Hum Pathol. 2003;34:680–9.View ArticlePubMedGoogle Scholar
  11. Rosenthal DI, Treat ME, Mankin HJ, Rosenbert AE, Jennings CL. Treatment of epithelioid hemangioendothelioma of bone using a novel combined approach. Skeletal Radiol. 2001;30:219–22.View ArticlePubMedGoogle Scholar
  12. Flucke U, Vogels RJ, de Saint Aubain Somerhausen N, et al. Epithelioid hemangioendothelioma: clinicopathologic, immunohistochemical, and molecular genetic analysis of 39 cases. Diagn Pathol. 2014;9:131.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Angelini A, Mavrogenis AF, Gambarotti M, Merlino B, Picci P, Ruggieri P. Surgical treatment and results of 62 patients with epithelioid hemangioendothelioma of bone. J Surg Oncol. 2014;109:791–7.View ArticlePubMedGoogle Scholar
  14. Bisbinas I, Karabouta Z, Georgiannos D, Lampridis V, Badekas A. Multifocal epithelioid hemangioendothelioma of the foot and ankle: a case report. J Orthop Surg. 2014;22:122–5.View ArticleGoogle Scholar
  15. Rong Y, Sato K, Yamamura S, Sugiura H, Katagiri H, Iwata H. Malignant hemangioendothelioma of the left calcaneus associated with fever and hematological abnormalities. Skeletal Radiol. 1997;26:64–6.View ArticlePubMedGoogle Scholar
  16. Dechambre SD, Coche EE, Roisin P, Van Eeckhout P, D’Odemont JP. Epithelioid hemangioendothelioma with solitary bone location associated to multiple lung and liver lesions. Acta Radiol. 1999;40:217–9.View ArticlePubMedGoogle Scholar
  17. Campanacci M, Boriani S, Giunti A. Hemangioendothelioma of bone: a study of 29 cases. Cancer. 1980;46:804–14.View ArticlePubMedGoogle Scholar
  18. Krajca-Radcliffe JB, Nicholas RW, Lewis JM. Multifocal epithelioid hemangioendothelioma in bone. Orthop Rev. 1992;21:973–5.PubMedGoogle Scholar
  19. Deyrup AT, Tighiouart M, Montag AG, Weiss SW. Epithelioid hemangioendothelioma of soft tissue: a proposal for risk stratification based on 49 cases. Am J Surg Pathol. 2008;32:924–7.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s) 2018

Advertisement